The JI Acurri Cytometers
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fu, T.-M.
Right arrow Articles by Donnelly, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fu, T.-M.
Right arrow Articles by Donnelly, J. J.
The Journal of Immunology, 1999, 162: 4163-4170.
Copyright © 1999 by The American Association of Immunologists

Dose Dependence of CTL Precursor Frequency Induced by a DNA Vaccine and Correlation with Protective Immunity Against Influenza Virus Challenge

Tong-Ming Fu1,*, Liming Guan*, Arthur Friedman*, Timothy L. Schofield{dagger}, Jeffrey B. Ulmer2,*, Margaret A. Liu2,* and John J. Donnelly2,*

Departments of * Virus and Cell Biology and {dagger} Biometrics, Merck Research Laboratories, West Point, PA 19486

Intramuscular injection of BALB/c mice with a DNA plasmid encoding nucleoprotein (NP) from influenza virus A/PR/8/34 (H1N1) provides cross-strain protection against lethal challenge with influenza virus A/HK/68 (H3N2). CTL specific for the H-2Kd-restricted epitope NP147–155 are present in these mice and are thought to play a role in the protection. To assess the effectiveness of NP DNA immunization in comparison with influenza virus infection in the induction of CTL responses, we monitored the frequency of CTL precursors (CTLp) in mice following i.m. injection with NP DNA or intranasal infection with influenza virus and showed that the CTLp frequency in NP DNA-immunized mice can reach levels found in mice that had been infected with influenza virus. We also measured the CTLp frequency, anti-NP Ab titers, and T cell proliferative responses in mice that were injected with titrated dosages of NP DNA and documented a correlation of the CTLp frequency and the Ab titers, but not proliferative responses, with the injection dose. Furthermore, we observed a positive correlation between the frequency of NP147–155 epitope-specific CTLp and the extent of protective immunity against cross-strain influenza challenge induced by NP DNA injection. Collectively, these results and our early observations from adoptive transfer experiments of in vitro activated lymphocytes from NP DNA-immunized mice suggest a protective function of NP-specific CTLp in mice against cross-strain influenza virus challenge.




This article has been cited by other articles:


Home page
J. Immunol.Home page
D. M. Carragher, D. A. Kaminski, A. Moquin, L. Hartson, and T. D. Randall
A Novel Role for Non-Neutralizing Antibodies against Nucleoprotein in Facilitating Resistance to Influenza Virus
J. Immunol., September 15, 2008; 181(6): 4168 - 4176.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
A. M. Talaat and K. Stemke-Hale
Expression Library Immunization: a Road Map for Discovery of Vaccines against Infectious Diseases
Infect. Immun., November 1, 2005; 73(11): 7089 - 7098.
[Full Text] [PDF]


Home page
J. Immunol.Home page
A. C. M. Boon, G. de Mutsert, D. van Baarle, D. J. Smith, A. S. Lapedes, R. A. M. Fouchier, K. Sintnicolaas, A. D. M. E. Osterhaus, and G. F. Rimmelzwaan
Recognition of Homo- and Heterosubtypic Variants of Influenza A Viruses by Human CD8+ T Lymphocytes
J. Immunol., February 15, 2004; 172(4): 2453 - 2460.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
G. Soboll, J. M. Whalley, M. T. Koen, G. P. Allen, D. G. Fraser, M. D. Macklin, W. F. Swain, and D. P. Lunn
Identification of equine herpesvirus-1 antigens recognized by cytotoxic T lymphocytes
J. Gen. Virol., October 1, 2003; 84(10): 2625 - 2634.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
E. G.-T. Wee, S. Patel, A. J. McMichael, and T. Hanke
A DNA/MVA-based candidate human immunodeficiency virus vaccine for Kenya induces multi-specific T cell responses in rhesus macaques
J. Gen. Virol., January 1, 2002; 83(1): 75 - 80.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
T. M. Pertmer, A. E. Oran, J. M. Moser, C. A. Madorin, and H. L. Robinson
DNA Vaccines for Influenza Virus: Differential Effects of Maternal Antibody on Immune Responses to Hemagglutinin and Nucleoprotein
J. Virol., September 1, 2000; 74(17): 7787 - 7793.
[Abstract] [Full Text]


Home page
J. Virol.Home page
C. H. Kim, M. C. Johnson, J. D. Drennan, B. E. Simon, E. Thomann, and J.-A. C. Leong
DNA Vaccines Encoding Viral Glycoproteins Induce Nonspecific Immunity and Mx Protein Synthesis in Fish
J. Virol., August 1, 2000; 74(15): 7048 - 7054.
[Abstract] [Full Text]


Home page
J. Virol.Home page
H. H. Nguyen, F. W. van Ginkel, H. L. Vu, M. J. Novak, J. R. McGhee, and J. Mestecky
Gamma Interferon Is Not Required for Mucosal Cytotoxic T-Lymphocyte Responses or Heterosubtypic Immunity to Influenza A Virus Infection in Mice
J. Virol., June 15, 2000; 74(12): 5495 - 5501.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.